Resilience and health-related quality of life in patients with pulmonary diseases receiving ambulatory oxygen therapy - 24-month follow-up results
Abstract
Purpose: There are scarce data on the development of health-related quality of life (HRQoL) over time and how psychological factors affect patients' adaptation to severe pulmonary diseases. This prospective 24-month follow-up study assessed HRQoL and its associations with anxiety, depression, resilience, and life satisfaction in pulmonary disease patients receiving ambulatory oxygen therapy.
Methods: We enrolled 47 patients who were prescribed ambulatory oxygen therapy for severe pulmonary diseases, and 3 months of data have been published previously. Patients completed five questionnaires at baseline and at 3, 6, 12 and 24 months: the 15D HRQoL instrument, the Hospital Anxiety and Depression Scale (HADS), the Life Satisfaction Scale-4, the Resilience Scale-25, and the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0). The primary outcome was the HRQoL at 24 months.
Results: At 24 months, data were available for 19 patients (response rate 40%). Patients had very low HRQoL at baseline, which decreased substantially during the 24-month follow-up. There was a strong inverse correlation between HRQoL and anxiety, depression and life satisfaction and a strong positive correlation with resilience. However, half of the patients with severe pulmonary diseases receiving ambulatory oxygen therapy who had better psychological functioning were happy with life and did not feel lonely at all. Patient satisfaction with assistive technology and services was high.…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 47 participants or records.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.